These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 35134709)

  • 1. The links between gut microbiota and obesity and obesity related diseases.
    Geng J; Ni Q; Sun W; Li L; Feng X
    Biomed Pharmacother; 2022 Mar; 147():112678. PubMed ID: 35134709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diet, Gut Microbiota, and Obesity: Links with Host Genetics and Epigenetics and Potential Applications.
    Cuevas-Sierra A; Ramos-Lopez O; Riezu-Boj JI; Milagro FI; Martinez JA
    Adv Nutr; 2019 Jan; 10(suppl_1):S17-S30. PubMed ID: 30721960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota: a target for intervention in obesity.
    Sehgal K; Khanna S
    Expert Rev Gastroenterol Hepatol; 2021 Oct; 15(10):1169-1179. PubMed ID: 34329563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.
    Kootte RS; Vrieze A; Holleman F; Dallinga-Thie GM; Zoetendal EG; de Vos WM; Groen AK; Hoekstra JB; Stroes ES; Nieuwdorp M
    Diabetes Obes Metab; 2012 Feb; 14(2):112-20. PubMed ID: 21812894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota and obesity: Impact of antibiotics and prebiotics and potential for musculoskeletal health.
    Klancic T; Reimer RA
    J Sport Health Sci; 2020 Mar; 9(2):110-118. PubMed ID: 32099719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism.
    Amabebe E; Robert FO; Agbalalah T; Orubu ESF
    Br J Nutr; 2020 May; 123(10):1127-1137. PubMed ID: 32008579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gut microbiota as a novel regulator of cardiovascular function and disease.
    Battson ML; Lee DM; Weir TL; Gentile CL
    J Nutr Biochem; 2018 Jun; 56():1-15. PubMed ID: 29427903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human gut microbiota and its interactive connections to diet.
    Milani C; Ferrario C; Turroni F; Duranti S; Mangifesta M; van Sinderen D; Ventura M
    J Hum Nutr Diet; 2016 Oct; 29(5):539-46. PubMed ID: 27161433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiota-Kidney Cross-Talk in Acute Kidney Injury.
    Gong J; Noel S; Pluznick JL; Hamad ARA; Rabb H
    Semin Nephrol; 2019 Jan; 39(1):107-116. PubMed ID: 30606403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT).
    Lee P; Yacyshyn BR; Yacyshyn MB
    Diabetes Obes Metab; 2019 Mar; 21(3):479-490. PubMed ID: 30328245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota alterations and dietary modulation in childhood malnutrition - The role of short chain fatty acids.
    Pekmez CT; Dragsted LO; Brahe LK
    Clin Nutr; 2019 Apr; 38(2):615-630. PubMed ID: 29496274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
    Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
    Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
    Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
    Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-fiber diets attenuate emphysema development via modulation of gut microbiota and metabolism.
    Jang YO; Kim OH; Kim SJ; Lee SH; Yun S; Lim SE; Yoo HJ; Shin Y; Lee SW
    Sci Rep; 2021 Mar; 11(1):7008. PubMed ID: 33772084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review.
    Li HY; Zhou DD; Gan RY; Huang SY; Zhao CN; Shang A; Xu XY; Li HB
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of the Gut Microbiome in Diabetes and Obesity-Related Kidney Disease.
    Zaky A; Glastras SJ; Wong MYW; Pollock CA; Saad S
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The gut microbiota, a new cardiovascular risk factor?].
    Chong-Nguyen C; Duboc H; Sokol H
    Presse Med; 2017; 46(7-8 Pt 1):708-713. PubMed ID: 28756077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota and obesity: an overview of microbiota to microbial-based therapies.
    Sheykhsaran E; Abbasi A; Ebrahimzadeh Leylabadlo H; Sadeghi J; Mehri S; Naeimi Mazraeh F; Feizi H; Bannazadeh Baghi H
    Postgrad Med J; 2023 Jun; 99(1171):384-402. PubMed ID: 37294712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gut-bone axis: how bacterial metabolites bridge the distance.
    Zaiss MM; Jones RM; Schett G; Pacifici R
    J Clin Invest; 2019 Jul; 129(8):3018-3028. PubMed ID: 31305265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiota and Obesity: A Role for Probiotics.
    Abenavoli L; Scarpellini E; Colica C; Boccuto L; Salehi B; Sharifi-Rad J; Aiello V; Romano B; De Lorenzo A; Izzo AA; Capasso R
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31703257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.